MEDICAMEQ / NSE / Biotechnology & Drugs

Medicamen Biotech

INR 247.417.85 (-5.09%) 1D

Last updated: 2026-06-16T06:38:35.623361+00:00

Price Chart

1Y Price Trend

Open415.75

High447.65

Low216.95

Close225.25

Volume42,044

Change-190.5

Change %-45.82%

Key Information

Ticker SymbolMEDICAMEQ

Current Price247.4

52-Week High447.65

52-Week Low216.95

Market Cap331.64

Beta1.2

Volume42,044

ISININE646B01010

Day High239.4

Day Low224

Open233.9

Recommendations

Target High454

Target Low220

Target Mean0

Target Median0

Risk Metrics

Overall RiskHigh risk

Board Risk46.4

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Medicamen Biotech Ltd is Rated Strong Sell - Markets Mojo14 days ago

Market news

Medicamen Biotech Ltd is Rated Strong Sell Markets Mojo

Medicamen Biotech Ltd Reports Strong Quarterly Turnaround Amid Long-Term Challenges - Markets Mojo17 days ago

Market news

Medicamen Biotech Ltd Reports Strong Quarterly Turnaround Amid Long-Term Challenges Markets Mojo

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges - Markets Mojo19 days ago

Market news

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges Markets Mojo

Medicamen Biotech Ltd is Rated Sell - Markets Mojo19 days ago

Market news

Medicamen Biotech Ltd is Rated Sell Markets Mojo

Medicamen Biotech Q4 FY26: Strong Quarter Masks Deeper Structural Concerns - Markets Mojo19 days ago

Market news

Medicamen Biotech Q4 FY26: Strong Quarter Masks Deeper Structural Concerns Markets Mojo

Medicamen Biotech FY26 net profit rises to ₹979.64 lakh - scanx.trade20 days ago

Market news

Medicamen Biotech FY26 net profit rises to ₹979.64 lakh scanx.trade

Medicamen Biotech Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 - marketscreener.com20 days ago

Market news

Medicamen Biotech Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 marketscreener.com

Medicamen Bio Standalone March 2026 Net Sales at Rs 54.68 crore, up 110.35% Y-o-Y - Moneycontrol.com20 days ago

Market news

Medicamen Bio Standalone March 2026 Net Sales at Rs 54.68 crore, up 110.35% Y-o-Y Moneycontrol.com